Daniel E. Austin and Christopher C. Mulligan discuss the latest developments in portable mass spectrometers
Ranitidine (Zantac) recall brings into question the analytical methods used to detect NDMA
Dr. Christopher Brown is a co-founder, VP, and CTO of 908 Devices Inc. (Boston, MA).
There has been a major push for standardization and quality control, notably through the use of gas chromatography-mass spectrometry
Metabolomics resides atop a Mount Rushmore of ‘omics’ disciplines
New take on scarlet snacks for the holidays and beyond